Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Treatment of Patients With Concussion

医学 降钙素基因相关肽 偏头痛 不利影响 脑震荡 皮疹 内科学 胃肠病学 麻醉
作者
Jennifer McVige,Megan Rooney,Dylan Lis
出处
期刊:Neurology [Lippincott Williams & Wilkins]
卷期号:98 (1 Supplement 1): S9.1-S9
标识
DOI:10.1212/01.wnl.0000801812.93958.f8
摘要

Objective Investigate the efficacy of 3 anti-Calcitonin Gene-Related Peptide monoclonal antibodies (anti-CGRP mAbs), fremanezumab, galcanezumab, and erenumab, in concussion patients with post-traumatic headache (PTH) with a migraine phenotype. Background A study using monoclonal antibodies in mice with mild traumatic brain injury saw improvements in cutaneous allodynia.1 A study from Denmark using erenumab for PTH found patients had an 82% decrease in the number of headache days. This study also demonstrated that 44% of patients had a reduction in HIT-6 score = 5 after 9–12 weeks of treatment.2. Design/Methods Retrospective chart review of patients diagnosed with PTH (n = 168) evaluated HIT-6, number of reported headache days, and the number of modifiable concussion variables (headache, dizziness, attention/concentration deficit, mood and sleep disturbance) prior to initiation of anti-CGRP mAbs and after at least 3 months of treatment were recorded. Results Patients saw a decrease in HIT-6 score ( p < 0.0001), with a mean difference of −4.26 from pre-treatment to at least 3 months after treatment. When evaluating 5 concussion symptom categories, patients experienced x¯ = 2.35 symptoms prior to anti-CGRP mAbs treatment, and x¯ = 1.67 after at least 3 months of treatment. Patients also experienced a decrease in the number of headache days per month (<0.0001) with a mean difference of −7.25 (range 0–30) headache days per month. Seven patients experienced adverse effects (1 patient had 2 different adverse effects), including injection site rash, fatigue, constipation, and dizziness. Only one patient discontinued medication due to adverse event. Conclusions Anti-CGRP mAbs used to treat PTH showed improved headache severity and frequency, as well as a decreased number of overall concussion symptoms. There was a subset of patients with a more robust response. Switching anti-CGRP mAbs was beneficial in some patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
ttxxcdx发布了新的文献求助10
1秒前
sichub完成签到 ,获得积分10
1秒前
烟花的应助被阳光雨堂采纳,获得10
2秒前
3秒前
3秒前
勤奋一一发布了新的文献求助10
3秒前
4秒前
难过冰萍完成签到,获得积分10
5秒前
Jasper的应助被ttxxcdx采纳,获得10
7秒前
慕青的应助被超帅的友菱采纳,获得10
7秒前
科研通AI6.2的应助被负责友易采纳,获得10
7秒前
斯文败类的应助被Cc采纳,获得10
8秒前
9秒前
9秒前
英姑的应助被阳光雨堂采纳,获得10
9秒前
9秒前
10秒前
10秒前
在水一方的应助被潇洒的亦凝采纳,获得10
10秒前
10秒前
11秒前
Sxw发布了新的文献求助10
13秒前
Owen的应助被cqzhang采纳,获得10
13秒前
Lucas的应助被九鱼采纳,获得10
13秒前
13秒前
13秒前
丘比特的应助被zzyh采纳,获得10
13秒前
14秒前
14秒前
15秒前
斯文败类的应助被义力古玛采纳,获得10
16秒前
鸟窝的应助被clelo采纳,获得10
16秒前
OaO发布了新的文献求助10
16秒前
willsong完成签到,获得积分10
16秒前
17秒前
17秒前
17秒前
华仔的应助被阳光雨堂采纳,获得10
17秒前
风趣的大门完成签到 ,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8171099
求助须知:如何正确求助?哪些是违规求助? 9563824
关于积分的说明 21772514
捐赠科研通 7762641
什么是DOI,文献DOI怎么找? 3430786
关于科研通互助平台的介绍 2554704
邀请新用户注册赠送积分活动 2475690